The candidate Wilms' tumour gene is involved in genitourinary development - PubMed (original) (raw)
. 1990 Jul 12;346(6280):194-7.
doi: 10.1038/346194a0.
Affiliations
- PMID: 2164159
- DOI: 10.1038/346194a0
The candidate Wilms' tumour gene is involved in genitourinary development
K Pritchard-Jones et al. Nature. 1990.
Abstract
Wilms' tumour is an embryonic kidney tumour thought to arise through aberrant mesenchymal stem cell differentiation and to result from loss of function of a 'tumour suppressor' gene(s). Both sporadic and syndrome-associated Wilms' tumours are accompanied by an increased frequency of abnormalities of the urinary tract and genitalia. Deletional analysis of individuals with the WAGR syndrome (for, Wilms' tumour, aniridia, genitourinary abnormalities and mental retardation) showed that a Wilms' tumour gene lies at chromosomal position 11p13. This led to the isolation of a candidate Wilms' tumour gene, encoding a zinc-finger protein which is likely to be a transcription factor. To gain insight into the role of this candidate gene in normal development and tumorigenesis, we have now performed in situ messenger RNA hybridization on sections of human embryos and Wilms' tumours. The candidate Wilms' tumour gene is expressed specifically in the condensed mesenchyme, renal vesicle and glomerular epithelium of the developing kidney, in the related mesonephric glomeruli and in cells approximating these structures in tumours. The other main sites of expression are the genital ridge, fetal gonad and mesothelium. These data suggest that (1) this candidate is indeed a Wilms' tumour gene, (2) the associated genital abnormalities are pleiotropic effects of mutation in the Wilms' tumour gene itself, in support of recent genetic analysis, and (3) this gene has a specific role in kidney development and a wider role in mesenchymal-epithelial transitions.
Similar articles
- Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K, Fleming S. Pritchard-Jones K, et al. Oncogene. 1991 Dec;6(12):2211-20. Oncogene. 1991. PMID: 1722569 - Wilms' tumour as a paradigm for the relationship of cancer to development.
Pritchard-Jones K, Hastie ND. Pritchard-Jones K, et al. Cancer Surv. 1990;9(3):555-78. Cancer Surv. 1990. PMID: 1966278 Review. - Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping.
Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. Gessler M, et al. Nature. 1990 Feb 22;343(6260):774-8. doi: 10.1038/343774a0. Nature. 1990. PMID: 2154702 - Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW, Watson JE, Poirier V, Mott MG, Berry PJ, Maitland NJ. Brown KW, et al. Oncogene. 1992 Apr;7(4):763-8. Oncogene. 1992. PMID: 1314370 - Wilms tumour: a developmental anomaly.
Hastie ND, Bickmore W, Pritchard-Jones K, Porteous DJ, van Heyningen V. Hastie ND, et al. Princess Takamatsu Symp. 1989;20:145-50. Princess Takamatsu Symp. 1989. PMID: 2562179 Review.
Cited by
- Mediators and mechanisms of heat shock protein 70 based cytoprotection in obstructive nephropathy.
Mazzei L, Docherty NG, Manucha W. Mazzei L, et al. Cell Stress Chaperones. 2015 Nov;20(6):893-906. doi: 10.1007/s12192-015-0622-z. Epub 2015 Jul 31. Cell Stress Chaperones. 2015. PMID: 26228633 Free PMC article. Review. - Genotype-phenotype analysis of pediatric patients with WT1 glomerulopathy.
Ahn YH, Park EJ, Kang HG, Kim SH, Cho HY, Shin JI, Lee JH, Park YS, Kim KS, Ha IS, Cheong HI. Ahn YH, et al. Pediatr Nephrol. 2017 Jan;32(1):81-89. doi: 10.1007/s00467-016-3395-4. Epub 2016 Jun 14. Pediatr Nephrol. 2017. PMID: 27300205 - A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome.
Little S, Hanks S, King-Underwood L, Picton S, Cullinane C, Rapley E, Rahman N, Pritchard-Jones K. Little S, et al. Pediatr Nephrol. 2005 Jan;20(1):81-5. doi: 10.1007/s00467-004-1649-z. Epub 2004 Oct 21. Pediatr Nephrol. 2005. PMID: 15503171 Review. - Pygo1 and Pygo2 roles in Wnt signaling in mammalian kidney development.
Schwab KR, Patterson LT, Hartman HA, Song N, Lang RA, Lin X, Potter SS. Schwab KR, et al. BMC Biol. 2007 Apr 10;5:15. doi: 10.1186/1741-7007-5-15. BMC Biol. 2007. PMID: 17425782 Free PMC article. - Characteristics of Nephroblastoma/Nephroblastomatosis in Children with a Clinically Reported Underlying Malformation or Cancer Predisposition Syndrome.
Welter N, Wagner A, Furtwängler R, Melchior P, Kager L, Vokuhl C, Schenk JP, Meier CM, Siemer S, Gessler M, Graf N. Welter N, et al. Cancers (Basel). 2021 Oct 7;13(19):5016. doi: 10.3390/cancers13195016. Cancers (Basel). 2021. PMID: 34638500 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical